AAAAAA
Results: 26-50/51
Authors:
Carbon, C
Poole, MD
Citation: C. Carbon et Md. Poole, The role of newer macrolides in the treatment of community-acquired respiratory tract infection. A review of experimental and clinical data, J CHEMOTHER, 11(2), 1999, pp. 107-118
Authors:
Tattevin, P
Cremieux, AC
Pottier, P
Huten, D
Carbon, C
Citation: P. Tattevin et al., Prosthetic joint infection: When can prosthesis salvage be considered?, CLIN INF D, 29(2), 1999, pp. 292-295
Authors:
Chemlal, K
Couvelard, A
Grange, MJ
Marmuse, JP
Charneau, C
Launay, O
Carbon, C
Yeni, P
Citation: K. Chemlal et al., Nodular lesions of the liver revealing multiple myeloma, LEUK LYMPH, 33(3-4), 1999, pp. 389-392
Authors:
Stelianides, S
Golmard, JL
Carbon, C
Fantin, B
Citation: S. Stelianides et al., Influence of socioeconomic status on features and outcome of community-acquired pneumonia, EUR J CL M, 18(10), 1999, pp. 704-708
Authors:
Guillemot, D
Maison, P
Carbon, C
Bouvenot, G
Imbs, JL
Eschwege, E
Citation: D. Guillemot et al., Pharmaceutical epidemiology: development and implementation in France, PRESSE MED, 28(9), 1999, pp. 493-499
Authors:
Carbon, C
Citation: C. Carbon, Prescribing practices for ENT infections - An interview with Professor C. Carbon, PRESSE MED, 28(8), 1999, pp. 420-422
Authors:
Amory-Rivier, C
Rieux, V
Azoulay-Dupuis, E
Carbon, C
Trombe, MC
Citation: C. Amory-rivier et al., Development of a septicaemic murine model allowing selection of virulent mutants of Streptococcus pneumoniae, PATH BIOL, 47(5), 1999, pp. 519-525
Authors:
Carbon, C
Citation: C. Carbon, Costs of treating infections caused by methicillin-resistant staphylococciand vancomycin-resistant enterococci, J ANTIMICRO, 44, 1999, pp. 31-36
Authors:
Aboulker, JP
Babiker, AG
Brun-Vezinet, F
Darbyshire, JH
Flandre, P
Gazzard, B
Nunn, AJ
Goodall, R
Aber, V
Bragman, K
Breckenridge, AM
Carbon, C
Charreau, I
Chene, G
Collis, P
Cooper, D
Dormont, J
Fiddian, P
Flepp, M
Goebel, FD
Hooker, M
Lange, J
Luthy, R
Peto, TEA
Reiss, P
Seligmann, M
Stone, AB
Thomis, J
Vella, S
Walckenaer, G
Warrell, D
Weller, IVD
Wilber, R
Yeni, P
Yeo, J
Withnall, R
Goudsmit, J
Huraux, JM
van der Noorda, J
Weiss, R
Boucher, C
Schuurman, R
Descamps, D
Jeffries, D
Tedder, R
Weber, J
Krzyanowski, C
Weverling, G
Citation: Jp. Aboulker et al., HIV-1 RNA response to antiretroviral treatment in 1280 participants in theDelta Trial: an extended virology study, AIDS, 13(1), 1999, pp. 57-65
Authors:
Abrams, D
Allan, D
Antunes, F
Breckenridge, A
Bruun, J
Cameron, W
Carbon, C
Chalmers, I
Chang, H
Chodakewitz, J
Clendenin, N
Clumeck, N
Collier, A
Collins, G
Cooper, E
Cooper, D
Danner, S
D'Aquila, R
DeGruttola, V
DeMasi, R
Dee, L
Deyton, L
Dixon, D
Farthing, C
Feinberg, J
Fischl, M
Flepp, M
Gartland, M
Gatell, J
Gazzard, B
Goebel, F
Gotzsche, P
Gringeri, A
Hall, D
Hamilton, J
Hammer, S
Hartigan, P
Heath-Chiozzi, M
Henry, K
Hill, A
Hirschel, B
Ioannidis, J
Kahn, J
Katlama, C
Katzenstein, D
Killen, J
King, E
de Loes, SK
Kravcik, S
Lange, J
Leavitt, R
Leonard, J
Maeland, A
Mannucci, P
Mathiesen, L
McDade, H
Meibohn, A
Melander, H
Merigan, T
Mulder, J
Myers, M
Neaton, J
Nessling, M
Perrin, L
Pettinelli, C
Phair, J
Phillips, A
Pinching, A
Poppa, A
Power, L
Reiss, P
Richman, D
Rooney, J
Rousseau, F
Rutherford, G
Salgo, M
Sandstrom, E
Saravolatz, L
Savidge, G
Schnittman, S
Schooley, R
Seligmann, M
Simberkoff, M
Skowron, G
Slade, P
Smith, D
Smith, RP
Soriano, V
Stanley, K
Stingl, G
Stoffels, P
Struthers, L
Tierney, C
Thompson, M
Van der Broeck, R
Van Leeuven, R
Van Weverling, G
Veenstra, J
Vella, S
Volberding, P
Weber, J
Winslow, D
Yeni, P
Yeo, J
Dormont, J
Sande, M
Weller, I
Babiker, A
Collins, R
Darbyshire, J
Duncan, W
Foulkes, M
Hughes, M
Peto, R
Peto, T
Walker, S
Citation: D. Abrams et al., Zidovudine, didanosine, and zalcitabine in the treatment of HIV infection:meta-analyses of the randomised evidence, LANCET, 353(9169), 1999, pp. 2014-2025
Authors:
Wolff, M
Joly-Guillou, ML
Farinotti, R
Carbon, C
Citation: M. Wolff et al., In vivo efficacies of combinations of beta-lactams, beta-lactamase inhibitors, and rifampin against Acinetobacter baumannii in a mouse pneumonia model, ANTIM AG CH, 43(6), 1999, pp. 1406-1411
Authors:
Lefort, A
Baptista, M
Fantin, B
Depardieu, F
Arthur, M
Carbon, C
Courvalin, P
Citation: A. Lefort et al., Two step acquisition of resistance to the teicoplanin-gentamicin combination by VanB-type Enterococcus faecalis in vitro and in experimental endocarditis, ANTIM AG CH, 43(3), 1999, pp. 476-482
Authors:
Dautrey, S
Rabbaa, L
Laouari, D
Lacour, B
Carbon, C
Farinotti, R
Citation: S. Dautrey et al., Influence of renal failure on intestinal clearance of ciprofloxacin in rats, ANTIM AG CH, 43(3), 1999, pp. 678-680
Authors:
Saleh-Mghir, A
Lefort, A
Petegnief, Y
Dautrey, S
Vallois, JM
Le Guludec, D
Carbon, C
Fantin, B
Citation: A. Saleh-mghir et al., Activity and diffusion of LY333328 in experimental endocarditis due to vancomycin-resistant Enterococcus faecalis, ANTIM AG CH, 43(1), 1999, pp. 115-120
Authors:
Blot, F
Faurisson, F
Bernard, N
Sellam, S
Friard, S
Tavakoli, R
Carbon, C
Stern, M
Bisson, A
Pocidalo, JJ
Caubarrere, I
Citation: F. Blot et al., Nebulized cyclosporine in the rat - Assessment of regional lung and extrapulmonary deposition, TRANSPLANT, 68(2), 1999, pp. 191-195
Authors:
Berlioz, F
Julien, S
Tsocas, A
Chariot, J
Carbon, C
Farinotti, R
Roze, C
Citation: F. Berlioz et al., Neural modulation of cephalexin intestinal absorption through the di- and tripeptide brush border transporter of rat jejunum in vivo, J PHARM EXP, 288(3), 1999, pp. 1037-1044
Authors:
Montravers, P
Maulin, L
Mohler, J
Carbon, C
Citation: P. Montravers et al., Microbiological and inflammatory effects of murine recombinant interleukin-10 in two models of polymicrobial peritonitis in rats, INFEC IMMUN, 67(4), 1999, pp. 1579-1584
Authors:
Rubinstein, E
Carbon, C
Citation: E. Rubinstein et C. Carbon, 6th International Symposium on New Quinolones - Proceedings of the 6th International Symposium on New Quinolones, Denver, Colorado, USA, November 15-17, 1998 - Foreword, DRUGS, 58, 1999, pp. XVII-XVII
Authors:
Carbon, C
Citation: C. Carbon, Bivalent cholera and typhoid vaccine - A viewpoint, DRUGS, 58(1), 1999, pp. 97-98
Authors:
Mommeja-Marin, H
Carbon, C
Citation: H. Mommeja-marin et C. Carbon, What is the place of fluoroquinolones in the treatment of community-acquired respiratory tract infections?, DRUGS, 57(6), 1999, pp. 851-853
Authors:
Dautrey, S
Felice, K
Petiet, A
Lacour, B
Carbon, C
Farinotti, R
Citation: S. Dautrey et al., Active intestinal elimination of ciprofloxacin in rats: modulation by different substrates, BR J PHARM, 127(7), 1999, pp. 1728-1734
Authors:
Tattevin, P
Breton, G
Carbon, C
Citation: P. Tattevin et al., Other beta-lactam antibiotics: Penems, carbapenems, and monobactams, CLINICAL INFECTIOUS DISEASES, 1999, pp. 265-271
Authors:
Andrieu, V
Encaoua, R
Carbon, C
Couvelard, A
Grange, MJ
Citation: V. Andrieu et al., Leukemic pleural effusion in B-cell prolymphocytic leukemia, HEM CELL TH, 40(6), 1998, pp. 275-278
Authors:
Carbon, C
Citation: C. Carbon, New anti-VZV drugs: Perspectives, MED MAL INF, 28, 1998, pp. 924-927
Authors:
Besson, C
Stelianides, S
Belmatoug, N
Silbermann-Hoffman, O
Couvelard, A
Joly, V
Carbon, C
Fantin, B
Citation: C. Besson et al., Multifocal osteonecrosis after chemotherapy in a patient with breast cancer, J RHEUMATOL, 25(12), 1998, pp. 2479-2480